Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

Journal of Cardiac Failure 2026 Open access

Read full text
Authors: Olives Nguyen, Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat, M Castrichini, Said Alsidawi, John Giudicessi, J. Geske, Richard T. Carrick, José Madrazo, Nicole Dellise
+40 more Mark A. Zenker, Thomas A. Boyle, N Reza, A. Owens, David S. Frankel, Prabhjot Hundal, Jamil Tajik, Patrycja Galazka, Myra Lewontin, Michael Ayers, Timothy C. Wong, M. Casey Flanagan, Sumeet S. Mitter, Arjun Kanwal, Ozlem Bilen, Sarah Baghdadi, Hirak Shah, Jared Kvapil, Paola Roldan, Loren Berenbom, Jill T. Jesurum, Denise Tootill, Alice Siqueira-Benzow, Mariko W. Harper, Danish Saleh, Lubna Choudhury, Isabela Valenta, M. Lang, Dermot Phelan, Dmitry Prizand, Neal Lakdawala, C Y Ho, Lusha W. Liang, Shepard D. Weiner, Sririam Ravi, Ahmed Abuzaid, Mohammed Makkiya, Jeremy Markowitz, Mark V. Sherrid, Ahmad Munir Masri
DOI: 10.1016/j.cardfail.2026.02.035
Cited by: 3
References: 6

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiovascular Function and Risk Factors Heart Failure Treatment and Management

Publication details

Journal / source
Journal of Cardiac Failure
Publisher
Elsevier BV
Publication date
1 March 2026
Language
EN